INIS
breasts
100%
cancer
84%
patients
67%
nmr imaging
48%
comparative evaluations
44%
screening
36%
radiations
32%
values
25%
tools
24%
diagnosis
23%
air
22%
doses
22%
energy
19%
size
19%
women
19%
detection
17%
populations
17%
tumors
16%
biopsy
16%
monitoring
16%
tyrosine
16%
evaluation
16%
computerized tomography
16%
carcinomas
16%
positron computed tomography
16%
grids
16%
diffusion
16%
rectum
16%
validation
16%
computed tomography
16%
Medicine and Dentistry
Mammography
82%
Breast Cancer
34%
Digital Mammography
32%
Radiation Exposure
32%
Magnetic Resonance Imaging
23%
Diagnostic Performance
23%
Neoplasm
20%
Breast Cancer Screening
18%
Screening
18%
Osimertinib
16%
Lobular Carcinoma
16%
Computer Assisted Tomography
16%
Diffusion MRI
16%
QT Prolongation
16%
Chemoradiotherapy
16%
Gadofosveset
16%
Digital Breast Tomosynthesis
16%
Positron Emission Tomography - Magnetic Resonance Imaging
16%
Preoperative Evaluation
16%
Tyrosine-Kinase Inhibitor
16%
Cancer Diagnosis
16%
Mass Screening
16%
Rectum Cancer
16%
Side Effect
16%
Transthoracic Biopsy
16%
Polyethylene Terephthalate
16%
Patient Monitoring
16%
Necrotizing Pneumonia
16%
Large Core Needle Biopsy
12%
Biopsy Technique
12%
Keyphrases
Contrast-enhanced Spectral Mammography
65%
Full-field Digital Mammography
32%
Radiation Exposure
32%
Diagnostic Performance
26%
Breast Cancer Screening Programme
19%
Imaging Tools
16%
Multi-reader multi-case Study
16%
Osimertinib
16%
New Drugs
16%
Contrast-enhanced Mammography
16%
Patient Monitoring
16%
Large Core
16%
Program Validation
16%
Multiplanar Reformatting
16%
Breast Cancer Staging
16%
Results Validation
16%
Breast Cancer Patients
16%
Preoperative Evaluation
16%
Chemoradiation
16%
Anti-scatter Grid
16%
Digital Breast Tomosynthesis
16%
Good Responders
16%
Diffusion-weighted Imaging
16%
CT-guided
16%
Colorectal Cancer
16%
Percutaneous Transthoracic Needle Biopsy
16%
Clinical Practice
16%
Gadofosveset
16%
Contrast Enhancement
16%
Invasive Lobular Breast Cancer
16%
